sileni

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimens
Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution
Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.
Results of esophagectomy for esophageal cancer in elderly patients: age has little influence on outcome and survival.
9315 Ipilimumab in pretreated metastatic uveal melanoma patients: safety and clinical efficacy
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the i...
Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma.
Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer.
Expression of defined genes identified by pretreatment tumor profiling: Association with clinical responses to the GSK MAGE- A3 immu...